60,000 Blood Pressure Tablets Recalled Nationwide, FDA Notice States

The recall was initiated because the ‘wrong ID’ was imprinted on the drugs.

The US Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The Food and Drug Administration indicated last week it is monitoring a recall of a blood pressure medication that impacts 60,000 tablets distributed around the United States

In a notice published on the FDA website on Feb. 11, 60,000 doxazosin tablets are under recall because the tablets/capsules were imprinted with the “wrong ID.” It’s not clear how the tablets were incorrectly marked.